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Short Communication
Protein-based nanoformulations for
α-tocopherol encapsulation
Nanoparticles of BSA and silk fibroin (SF) with entrapped α-tocopherol were pro-
ducedviaultrasonic emulsification.Populationswithparticle size of 200–300nmand
highly negatively charged were obtained for all the tested formulations. Entrapment
efficiencies of around 99% revealed the effective encapsulation of α-tocopherol into
the produced nanoformulations. Generally, these nanodevices did not induce signif-
icant cytotoxicity to human skin keratinocytes for all the concentrations tested. The
developed formulations showed free radical scavenging of ABTS.+ ability resulting
from the synergistic effect between the proteins in formulation and the entrapped
tocopherol. Overall, the results contribute for the establishment of BSA:VO and
BSA:SF:VO as biodegradable and non-toxic nanoformulations for the functional-
ization of textile devices and controlled delivery of tocopherol into the skin.
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1 Introduction
α-Tocopherol, vitamin E, is the most active, lipid soluble,
membrane-bound antioxidant [1–3]. It plays an important role
in the prevention and treatment of some chronic and age-related
diseases, such as cardiovascular diseases, atherosclerosis, cancer,
arthritis, Alzheimer’s and Parkinson’s [4]. The supplementation
of tocopherol offers also skin protection against harmful-free
radicals at which it is exposed [5]. α-Tocopherol acts as an an-
tioxidant by donating one of its electrons to a free radical, and
stabilizing it. The newly formed radical can bind to another rad-
ical, resulting in a non-radical product, or it can reconvert to
α-tocopherol. This radical is quite stable due to the unpaired
electron of the atom of oxygen which is delocalized in the aro-
matic ring [6].
The delivery of tocopherol has been provided in an emul-
sion or a nanoencapsulation form. Polymeric nanoparticles or
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Abbreviations: ABTS, 2,2’-Azino-bis(3-ethylbenzothiazoline-6-
sulfonic acid) diammonium salt; BSA, bovine serum albumin; DLS,
dynamic light scattering; DMEM, dubelcco’s modified eagle’s medium;
DMSO, dimethyl sulfoxide; EtOH, ethanol; FBS, fetal bovine serum;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
PBS, phosphate buffer solution; PCS, photon correlation spectroscopy;
PDI, polydispersity; SF, silk fibroin; STEM, scanning transmission
electron microscopy; TOC, tocopherol; UV-Vis, ultraviolet visible; VO,
vegetable oil
liposomes have been achieved by a number ofmethodologies, in-
cluding emulsion, microemulsion polymerization, interfacial or
precipitationpolymerization, emulsion evaporation, solvent dis-
placement, etc. [7, 8]. Despite their encapsulation ability, some
drawbacks related with surface area, solubility, stability, con-
trolled release, skin irritation, degradation and loading have
hampered the efficient application [9]. Nanocarriers with in-
creased surface area and lipid carrier abilitywould present higher
stability and higher drug loading capacity.
Herein, we explore the capacity of protein-based nanocarri-
ers to encapsulate tocopherol. The nanoformulations based on
BSA and silk fibroin (SF) produced by ultrasonication would in-
crease tocopherol entrapment. These two proteins were chosen
due to their antioxidant ability and known application on the
production of drug delivery carriers. The antioxidant properties
of both proteins and tocopherol [10, 11] are expected to act in
synergistically by increasing the overall scavenging oxidation of
ABTS.+
The rationale of the study is to formulate tocopherol into
protein-based nanocarriers to produce non-toxic and stable
preparations which can be applied onto textile surfaces (gauzes,
bandages, etc.) for medical and cosmetic purposes.
2 Materials and methods
Unless otherwise stated, all of the solvents and reagents used in
this study were commercially supplied by Sigma−Aldrich and
used as received.Cocoonswere donated byDr. SilviaCappellozza
from “Sezione Specializzata per la Bachicoltura” (Padova).
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The experimental setup used for nanoparticles production
was composed of a probe type ultrasound source (20 kHz
Sonics & Materials Vibracell CV 33) fitted with a 3 mm di-
ameter titanium micro tip. Power delivery was controlled as
percentage amplitude (40%). The reaction vessel was an open
glass cell (diameter 19 mm, and height, 75 mm) containing the
sample solution (16 mL). The sonochemical reactor tempera-
ture was controlled via a thermostatted water bath with a freezer
exchanger place within a thermojacket cell, which gave a steady
operating temperature (10 ± 1°C).
The nanoparticles were prepared by an adaptation of Suslick’s
method and considering previous conditions reported by Silva
et al. [12]. Briefly, the bottom of a high-intensity ultrasonic horn
was positioned at the interface of the protein aqueous solution
and vegetable oil/tocopherol at an amplitude of 40% at 10°C
(±1) for 3 min. The ratio of aqueous/organic phase (%) used
was 95/5 and the concentrations of proteins used were 10 gL−1
BSA solution in PBS pH 7.4 and 1 gL−1 SF solution (previously
prepared as described by Rockwood et al. [13]). The amount of
α-tocopherol used for encapsulation was 10 and 20% (v/v %),
defined as the percentage related with the amount of oil in the
final formulation ratio. Their characterization was made based
on size distribution and zeta-potential (ζ-potential), at pH 7.4
(PBS buffer) and at 25°C, by using dynamic light scattering in a
Malvern zetasizer NS, by photon correlation spectroscopy (PCS)
and by electrophoretic laser Doppler anemometry, respectively.
Each sample wasmeasured in triplicate and results are presented
as mean value± standard deviation. Nanoemulsions, in suspen-
sion, were stored at 4°C for a period of 20 weeks. After prede-
termined storage times, the stability parameters, particles size,
polydispersity and zeta-potential, were determined as described
above.
After synthesis, the nanoparticles-containing phase was col-
lected by centrifugation (1000 × g for 45 min) using centricon
tubes (AmiconUltra-15,Millipore), a centrifugal filter unit con-
taining a cellulose membrane with a molecular weight cut-off of
100 kDa. The free proteins, BSA (66 kDa) and SF (˃25 kDa)
in the aqueous phase after separation were quantified using
the Bradford method [14] and the efficiency of nanoemulsions
formation was determined by using the formula: where [C]i
and [C]f is the initial and final concentration of the protein in
the aqueous solution, respectively. Each sample was assayed in
triplicate
Nanoemulsions formation(%) =C i − [C] f
[C] i
× 100.
The morphology of nanoparticles was evaluated by STEM
analysis. The diluted nanoparticles suspensions were dropped
on copper grids with a 400 mesh carbon film, 3 mm in diameter.
The shape and morphology of the microspheres were observed
by using a NOVA Nano SEM 200 FEI instrument.
After synthesis, the nanoparticles-containing phase was col-
lected by centrifugation (1000 × g for 45 min) using centricon
tubes (AmiconUltra-15,Millipore), a centrifugal filter unit con-
taining a cellulose membrane with a molecular weight cutoff of
30 kDa. The non-encapsulated tocopherol was detected by UV-
Vis spectroscopy in the lower part of the centricon tubes. For this,
spectral curves of stock solutions and of the solutions resulting
from centrifugation were measured by UV-Vis spectroscopy.
In order to evaluate the nanoparticles cytotoxicity,
NCTC2544 cell line (human skin keratinocytes), was cultured
in DMEM media, and supplemented with 7% FBS and 1%
(v/v) penicillin/streptomycin solution. Cells were maintained in
75-cm2 tissue culture flasks at 37°C in a humidified atmosphere
with 5% CO2. The cell culture medium was renewed twice a
week. Subculture was performed when confluence reached val-
ues near 80–90%.
Cells were seeded at a density of 7500 cells/well on a 96-well
tissue culture plate, the day before the experiments. NCTC 2544
cells were exposed to four concentrations (50, 100, 200, and
500μg/mL) of nanoparticles and one concentration of free BSA,
SF and TOC. The concentration of free BSA, SF and tocopherol
correspond to the amount present in the highest concentration
of nanoparticles tested. Cells incubated with DMSO (30% of the
total volume) and cells without the addition of the compounds
were used as positive and negative controls of cytotoxicity, re-
spectively. Cells were incubated at 37°C in a humidified atmo-
sphere with 5%CO2. At the end of 24 h of contact, cell metabolic
activity was assessed by MTT viability assay [15]. After incuba-
tion, the medium with nanoparticles was removed and 110 μL
of medium with MTT (5 mg/mL) was added to each well, and
cells were further incubated at 37°C for 2 h. The MTT solution
was carefully decanted, and formazan crystals were dissolved in
110 μL of a DMSO/EtOH (1:1(v/v)) mixture. Colour was mea-
sured with 96-well plate reader at 570 nm in a microplate reader
SpectraMax Plus (Molecular Devices).
The antioxidant activity of nanoparticles was evaluated by
ABTS radical cation (ABTS.+) scavenging activity according to
the method described by Re et al. [16] with some modifications.
ABTS.+ was produced by reacting 38.41 mg ABTS (at a final
concentration 7 mM) and 6.623 mg potassium persulfate (at a
final concentration 2.45 mM) in 10 mL demineralized H2O in
an Erlenmeyer flask and keeping the mixture in the dark at 26 ±
3°C for 12–16 hwithmagnetic stirring. An aliquot of blue–green
ABTS.+ solution was then diluted with 95% ethanol to give an
absorbance of 0.45 ± 0.01 at 734 nm. For this, ABTS.+ adjusted
solution (2.5 μL) and ethanol (197.5 μL) were mixed in a semi-
micro cuvette and the absorbance at 734 nm corresponding to
the blank (E1) was recorded (Spectronic Genesys 5, Germany).
For each sample test, five concentrations (10, 50, 100, 250 and
500μg/mL) were analyzed. The reaction mixture was allowed to
stand for exactly 6minwith the ABTS solution (E2). TheABTS.+
scavenge (%) was calculated as
ABTS.+scavenge (%) =
(
E 1 − E 2
E 1
)
× 100.
Trolox (6-hydroxy-2,5,7,8-tetramethychroman- 2-carboxylic
acid) was used an antioxidant standard. Trolox was prepared in
ethanol for use as a stock standard andmixedwithABTS solution
for scavenging determination.
3 Results and discussion
The developed nanoformulations were characterized by DLS
and visualized by STEM. From Table 1 and Fig. 1 it is clear
that both BSA and SF proteins were successfully converted into
spherical and smooth nanoemulsions by using high-intensity
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Table 1. Size, PDI, zeta-potential and storage stability of optimized nanoformulations as function of α-tocopherol loading
Formulation Size
(d.nm)
Pdi Size
(d.nm)
PDI Zeta-
potential
(mV)
Stability
(days)
Nanoparticles
formation
Encapsulated
α-tocopherol
Before
filtration
Before
filtration
After
filtrationa)
After
filtrationa)
BSA:VO (0% TOC) 242.1 0.049 179 0.138 −36
BSA:VO (10% TOC) 279.9 0.092 173.6 0.135 −36.1 99% 99%
BSA:VO (20% TOC) 296.8 0.138 186.1 0.231 −29.5 123
BSA:SF:VO (0%TOC) 319.4 0.065 165.4 0.113 −36.8
BSA:SF:VO (10% TOC) 306.1 0.122 159.1 0.146 −33.6
BSA:SF:VO (20% TOC) 302.2 0.095 159.2 0.208 −40.4
a)Filtration means that nanoparticles were filtered with a 0.20 μm filter from Whatman for samples homogeneity
Figure 1. STEM microphotographs (100 000× magnification) of proteinaceous nanoparticles: (A) BSA and (B) BSA:SF obtained with a
concentration of 10 g/L and 1 g/L of BSA and SF, respectively; (C) visual aspect of both formulations, left: BSA:VO (20%TOC), right:
BSA:SF:VO (20%TOC).
ultrasound (Fig. 1). This morphology is known to offer the
highest encapsulation potential as well as high release per-
formance and drug protection, providing the minimum con-
tact with the aqueous environment [12]. The mechanism of
protein-based nanoemulsions formation using ultrasounds was
already reported by Silva et al. [12]. They postulate that in an
aqueous phase, proteins form stable 3D structures based on the
balance between the outer hydrophilic segments covering the in-
ner hydrophobic segments in a conformation ofminimal energy.
When high shear forces like ultrasound are applied to the bipha-
sic system of water/oil, the proteins tend to adapt their structure
andmigrate to the interface.Depending on the protein structure,
its adaptation may include a 3D modification of protein [12].
The accommodation of SF to the water/oil interface tends to
promote self-assembly and β-sheet formation [12]. In all cases,
the protein seems to form a shell with hydrophobic characteris-
tics near the organic solvent and hydrophilic characteristics near
water. Our results (Table 1) suggest that proteins are adsorbed at
the interface in a multilayer fashion. Nanoemulsions formation
is completely independent of the presence of cysteine, and the
high shear forces are a driving force to achieve stable particles.
The size of produced nanodevices wasmeasured before and after
filtrationwith 0.2μmfilters. All the formulations present narrow
size distribution between 200–300 nmwith low polydispersity. It
can be depicted from Table 1 that depending on their composi-
tion the nanoparticle formulations present different particle size.
Formulations containing only BSA in vegetable oil present lower
particle size when compared with the formulations-containing
SF in their composition. SF behavior during particle formation
is responsible for this difference. All the formulations produced
are homogeneous with low values of PDI (from 0.1–0.2) which is
a good indicator regarding future applications. The zeta poten-
tial is an important parameter in nanoparticles characterization
which allows us to predict their stability over time. Long term
stability of produced nanoparticles has been verified which is in
accordance with the zeta potential data obtained. The nanopar-
ticles are high negatively charged indicating high repulsive forces
and low probability of agglomeration. All the developed formu-
lations present similar zeta potential values (30 mV) even for
the formulations with high amount of tocopherol encapsulated.
As reported previously by Silva et al. [12], nanoemulsions
produced with BSA and SF under ultrasonic field can reach
formation yields very close to 100%. In this study, we ver-
ify that after centrifugation of the produced nanoemulsions
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Figure 2. Relative viability of NCTC 2544 (human skin keratinocytes) evaluated with the MTT assay, after 24 h incubation in medium-
containing BSA:VO (0, 10 and 20% TOC), BSA:SF:VO (0, 10 and 20% TOC) and one concentration of free BSA, SF and TOC. The
concentration of free BSA, SF and TOC correspond to the amount present in the highest concentration of nanoparticles tested.
Cells incubated with culture medium were used as negative control and cells incubated with 30% DMSO as positive control of
cytotoxicity. Data were determined in relation to the life control. Results are the mean ± SD of triplicate of three independent
experiments.
Figure 3. ABTS.+ radical scavenging activity of the various
nanoformulations compared with Trolox. The values are themean
± SD of three parallel measurements.
with centricon tubes, the amount of material separated from
nanoparticles was negligible. Thus all of the initial materi-
als introduced in the formulation formed nanoemulsions. The
entrapment efficiency indicates the amount of compound en-
trapped into the polymeric matrix. Herein, the theoretical en-
trapment efficiency is almost maximum. For both loading per-
centages of tocopherol, the entrapment efficiency was around
99% (data not shown). At the moment of nanoparticles forma-
tion, all the tocopherol is entrapped into the oil phase due to
its lipophilic nature. These results are in accordance with the
data reported in literature about encapsulation of hydrophobic
compounds presenting entrapment efficiencies greater than 90%
[7].
Considering future applications in skin, it was imperative to
evaluate the potential cytotoxicity of the nanoformulations. To
assess the potential cytotoxic effect of the nanoparticles, human
skin keratinocytes (NCTC 2544) cells were used asmodel of gen-
eral cytotoxicity. Analyzing Fig. 2, the tested nanoparticles did
not show any significant toxic effect for any of the tested con-
centrations. The BSA:VO nanoparticles presented cell viability
higher than 88.5 ± 11.5 % and the BSA:SF:VO nanoparticles
presented cell viability higher than 90.6 ± 8.2 %.
There was an increase on the scavenging activity of trolox and
nanoparticles-containing tocopherol increasing the concentra-
tion of each sample. Trolox was used as a control to compare the
antioxidant capacity of each formulation and the degree of inhi-
bition was calculated as described in 2.9. The x-axis represents
the concentration of formulations (μM) and the y-axis repre-
sents the scavenging effect (Fig. 3). Trolox and the nanoparti-
cles with tocopherol display different plots, indicating significant
differences in the scavenging activity of ABTS•+ radical cations.
The most similar behavior is observed for the formulation com-
posed of BSA and SF with 20% tocopherol incorporated. The
formulation-containing BSA with 20% tocopherol present also
a significant antioxidant activity however in a lower extent. The
antioxidant nature of BSA [11], resulting from its ability to bind
molecules such as metal ions, fatty acids, drugs and hormones,
and of SF [10, 17, 18] acts synergistically enhancing the effect
of tocopherol on the ABTS.+ scavenging. The mechanistic in-
sights behind this may be explained by the diffusion of the en-
trapped tocopherol through the permeable nanoscaled matrix
to the medium. The vitamin E which is close or attached to the
nanoparticles surface can also be burst and act on the scavenging
effect. The proteins present at the interface betweenmedium and
entrapped tocopherol contribute to the increased scavenging ef-
fect observed. The nanoscaled particles produced also contribute
to tocopherol behavior by increase the surface area, solubility
and stability of tocopherol. Thus, the concomitant antioxidant
effect of BSA, SF and tocopherol in the new formulations is very
promising for the development of antioxidant-based applica-
tions for skin treatment.
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Practical application
α-Tocopherol is an anti-oxidant agent used in several medi-
cal and cosmetic applications. Due to its sensitivity it must
be protected from light, heat and oxygen. Liposomes, poly-
meric and protein-based nanodevices have been applied
for its entrapment and delivery. The incorporation into li-
posomes or nanoparticles core is hindered by its lipophilic-
ity. Nanoparticles of BSA and silk fibroin (SF) are produced
by ultrasounds in a biphasic system consisting of an aque-
ous protein solution and vegetable oil (VO). The developed
nanoparticles are promising vehicles to be used in a wide
range of applications like textile supports for skin treat-
ment. Cotton fabrics can be functionalized within these
nanoparticles to produce textile devices for a continuous
skin care. The release of Vitamin E from the textiles into the
skin will turn into long life effect of detoxification of free
radicals, anti-inflammatory, repair and regeneration, and
regulation of skin’s moisture balance.
4 Concluding remarks
The protein-based nanocarriers developed offer advantages over
other conventional passive delivery devices. They have high sur-
face area, high solubility, improved stability, no toxicity and drug
loading improvement. These nanoemulsions are easy to produce
and low timeconsuming.Their antioxidantpower resulting from
tocopherol and proteins action, make them promising devices
for cosmetic applications.
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